Clinical Trials Directory

Trials / Completed

CompletedNCT01938937

The Effect of Acute Transcranial Bright Light on Anxiety Symptoms

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
University of Oulu · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if transcranially administered bright light has acute effect on anxiety symptoms.

Detailed description

Subjects (n=30) with anxiety symptoms will be recruited into the study. To be included into the study, subjects have to get at least seven points in BAI(Becks Anxiety Inventory). At the beginning of the study subject will be randomly assigned to 12 minutes of acute transcranial bright light or placebo exposure group. Anxiety symptoms will be measured using Spielberger State-Trait Anxiety Inventory (STAI, form Y1)self-rating questionnaire just before and 10 and 110 minutes after the experiment.

Conditions

Interventions

TypeNameDescription
DEVICETranscranial bright light device
DEVICETranscranial sham device

Timeline

Start date
2012-03-01
Primary completion
2014-02-01
Completion
2014-02-01
First posted
2013-09-10
Last updated
2014-02-26

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT01938937. Inclusion in this directory is not an endorsement.